(19)
(11) EP 4 392 413 A1

(12)

(43) Date of publication:
03.07.2024 Bulletin 2024/27

(21) Application number: 22860750.3

(22) Date of filing: 25.08.2022
(51) International Patent Classification (IPC): 
C07D 401/06(2006.01)
C07D 405/06(2006.01)
A61K 31/40(2006.01)
A61P 25/28(2006.01)
C07D 205/04(2006.01)
C07D 487/04(2006.01)
A61P 25/16(2006.01)
A61P 29/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/40; A61P 25/16; A61P 25/28; A61P 29/00; C07D 487/04; C07D 207/08; C07D 333/34; C07D 307/64; C07D 277/16; C07D 233/64
(86) International application number:
PCT/IB2022/057951
(87) International publication number:
WO 2023/026222 (02.03.2023 Gazette 2023/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.08.2021 IN 202121038491

(71) Applicant: Zydus Lifesciences Limited
Gujarat 382481 (IN)

(72) Inventors:
  • AGARWAL, Sameer
    Gandhinagar, Gujarat 382481 (IN)
  • PARMAR, Deven V.
    Gandhinagar, Gujarat 382481 (IN)
  • JAIN, Mukul
    Gandhinagar, Gujarat 382481 (IN)
  • SHARMA, Rajiv
    Gandhinagar, Gujarat 382481 (IN)
  • PHILIP, Binu
    Gandhinagar, Gujarat 382481 (IN)
  • PATEL, Harilal
    Gandhinagar, Gujarat 382481 (IN)
  • CHATTERJEE, Abhijit
    Gandhinagar, Gujarat 382481 (IN)
  • VISWANATHAN, Kasinath
    Gandhinagar, Gujarat 382481 (IN)

(74) Representative: Potter Clarkson 
Chapel Quarter Mount Street
Nottingham NG1 6HQ
Nottingham NG1 6HQ (GB)

   


(54) TREATMENT FOR NEUROINFLAMMATORY DISORDERS